ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates reply

被引:0
|
作者
Voysey, Merryn [1 ]
Pollard, Andrew J. [1 ]
机构
[1] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 7LE, England
来源
LANCET | 2021年 / 397卷 / 10291期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2248 / 2248
页数:1
相关论文
共 50 条
  • [1] ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates
    McQuade, Elizabeth T. Rogawski
    Platts-Mills, James A.
    LANCET, 2021, 397 (10291): : 2247 - 2248
  • [2] ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant REPLY
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06): : 571 - 572
  • [3] Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
    McQuade, Elizabeth T. Rogawski
    Breskin, Alexander
    LANCET, 2021, 398 (10304): : 933 - 935
  • [4] Fixed Drug Eruption after ChAdOx1 nCoV-19 Vaccine
    Jabri, F. E.
    Kastalli, S.
    Ferchichi, K.
    Dabbeche, S.
    Daghfous, R.
    Aidli, S. E.
    DRUG SAFETY, 2022, 45 (10) : 1197 - 1197
  • [5] Process-Related Impurities in the ChAdOx1 nCov-19 Vaccine
    Krutzke, Lea
    Roesler, Reinhild
    Allmendinger, Ellen
    Engler, Tatjana
    Wiese, Sebastian
    Kochanek, Stefan
    MOLECULAR THERAPY, 2022, 30 (04) : 342 - 342
  • [6] Cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine
    Abdulla, Mansoor C.
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2022, 13 (04) : 263 - 264
  • [7] Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies
    Thookhamme, Chayapa
    Navinpipat, Manassamon
    Sasakul, Aimwipa
    Pattarakosol, Pakthipa
    Lertchaisataporn, Kamoltip
    Tawinprai, Kriangkrai
    Praditsuktavorn, Pannee
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2023, 12 (02) : 107 - 115
  • [8] A case report of ChAdOx1 nCoV-19 vaccine–associated encephalitis
    Junko Takata
    Simon M. Durkin
    Solomon Wong
    Michael S. Zandi
    Josephine K. Swanton
    Tumena W. Corrah
    BMC Neurology, 21
  • [9] Process-related impurities in the ChAdOx1 nCov-19 vaccine
    Krutzke, L.
    Roesler, R.
    Wiese, S.
    Kochanek, S.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A19 - A19
  • [10] Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccine
    Ahmer, Sadaf
    Bourke, Jack
    Ardakani, Nima Mesbah
    BMJ CASE REPORTS, 2022, 15 (07)